Paper13636626
An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.
RONA G and 3 others. AMA Arch Pathol, 1959. Cited by 865 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Papers, record 13636626. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13636626
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Isoproterenol | Major topic |
| Myocardial Infarction | Major topic |
| Sympathomimetics | Major topic |
| Animals | |
| Rats |
Source PubMed
Cited by156
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 865 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,978,498 | Tanshinone IIA alleviates inflammation and apoptosis in myocardial ischemia-reperfusion injury by modulating the MALT1/NF-κB/NLRP3 signaling axis. | Histol Histopathol | 2026 | https://conductscience.org/library/papers/41978498 | PubMed |
| 40,898,254 | Adropin as a therapeutic candidate for HFpEF: evidence of oxidative stress mitigation via Nrf2/HO-1 signaling. | Lipids Health Dis | 2025 | https://conductscience.org/library/papers/40898254 | PubMed |
| 40,822,339 | Active and passive targeted delivery of anti-ferroptotic therapy for post-resuscitation myocardial dysfunction. | iScience | 2025 | https://conductscience.org/library/papers/40822339 | PubMed |
| 40,207,621 | Transplantation of exogenous mitochondria mitigates myocardial dysfunction after cardiac arrest. | Elife | 2025 | https://conductscience.org/library/papers/40207621 | PubMed |
| 40,141,033 | Negative Alterations in the Respiratory Activity of Isolated Crude Heart Mitochondria Following In Vivo Isoproterenol Injection in Rats Are Not Observed in Heart Homogenate Suggesting That the Isolation Procedure Generates Experimental Artefacts. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141033 | PubMed |
| 39,261,890 | Ellagic acid-enhanced biocompatibility and bioactivity in multilayer core-shell gold nanoparticles for ameliorating myocardial infarction injury. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39261890 | PubMed |
| 38,841,261 | Animal models of Takotsubo syndrome: bridging the gap to the human condition. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38841261 | PubMed |
| 38,509,456 | A singleton pregnancy with placental chorioangioma and hydrops fetalis complicated with mirror syndrome and ritodrine-induced side effects: a case report. | BMC Pregnancy Childbirth | 2024 | https://conductscience.org/library/papers/38509456 | PubMed |
| 38,444,056 | mTORC1 hyperactivation and resultant suppression of macroautophagy contribute to the induction of cardiomyocyte necroptosis by catecholamine surges. | Physiol Rep | 2024 | https://conductscience.org/library/papers/38444056 | PubMed |
| 37,967,221 | Impaired end joining induces cardiac atrophy in a Hutchinson-Gilford progeria mouse model. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37967221 | PubMed |
| 37,868,970 | The Immunology of Takotsubo Syndrome. | Front Immunol | 2023 | https://conductscience.org/library/papers/37868970 | PubMed |
| 37,759,657 | Macrophages in the Inflammatory Phase following Myocardial Infarction: Role of Exogenous Ubiquitin. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37759657 | PubMed |
| 37,051,097 | Icariin ameliorates oxidative stress-induced inflammation, apoptosis, and heart failure in isoproterenol-challenged Wistar rats. | Iran J Basic Med Sci | 2023 | https://conductscience.org/library/papers/37051097 | PubMed |
| 36,834,573 | Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834573 | PubMed |
| 36,563,015 | Refining the reproducibility of a murine model of stress-induced reversible cardiomyopathy. | Am J Physiol Heart Circ Physiol | 2023 | https://conductscience.org/library/papers/36563015 | PubMed |
| 35,402,664 | Positive effect of Periostin on repair of Isopreternol induced ischemic damaged cardiomyocyte: an in vitro model. | Regen Ther | 2022 | https://conductscience.org/library/papers/35402664 | PubMed |
| 34,604,361 | Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1-RIPK3-Dependent Pathway in Mice. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/34604361 | PubMed |
| 34,572,106 | Electrophysiological Remodeling: Cardiac T-Tubules and ß-Adrenoceptors. | Cells | 2021 | https://conductscience.org/library/papers/34572106 | PubMed |
| 34,415,184 | Immune cell β2-adrenergic receptors contribute to the development of heart failure. | Am J Physiol Heart Circ Physiol | 2021 | https://conductscience.org/library/papers/34415184 | PubMed |
| 34,266,475 | Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence. | BMC Pharmacol Toxicol | 2021 | https://conductscience.org/library/papers/34266475 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/13636626
GET https://conductscience.org/api/papers/v1/13636626/cited_by?page=2